Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana S. Najera,Christopher J. Ricketts,Laura S. Schmidt, Julia I. Medina,Keita Saito,Lilia Ileva,Jeffrey R. Brender,Amy M. James,Cody J. Peer,Brad Gouker,Baktiar O. Karim,Olga Chernova, Catherine Wells,Ming-Hui Wei,Youfeng Yang,Xiaohu Zhang,Carleen Klumpp-Thomas,Jameson Travers,Lu Chen,Kelli M. Wilson,Sameer H. Issaq,William D. Figg,Simone Difilippantonio,Joseph D. Kalen,Murali C. Krishna,Craig J. Thomas,Michele Ceribelli,Christine M. Heske,Daniel R. Crooks,Jordan L. Meier MOLECULAR CANCER THERAPEUTICS(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper